The effect of dehydroepiandrosterone sulfate (DHEAS) on myotonia: Intracellular studies

Internal Medicine

Volumn 44, Issue 12, 2006, Pages 1247-1251

  Nakazora, Hiroshi ^a   Kurihara, Teruyuki ^a  

^a TOHO UNIVERSITY OHASHI MEDICAL CENTER   (Japan)

Author keywords

Dehydroepiandrosterone sulfate; Insertion myotonia; Intracellular recording; Isometric twitch tension; Mexiletine; Mto mice

Indexed keywords

CHLORIDE CHANNEL; MEXILETINE; PRASTERONE; PRASTERONE SULFATE; REAGENT; SODIUM CHANNEL BLOCKING AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; HEMIDIAPHRAGM; MOUSE; MUSCLE ISOMETRIC CONTRACTION; MUSCLE STRENGTH; MUSCLE TWITCH; MYOTONIA; MYOTONIC DYSTROPHY; NONHUMAN; RAT; TREATMENT OUTCOME; TYRODE;

ACTION POTENTIALS; ANIMALS; DEHYDROEPIANDROSTERONE SULFATE; DISEASE MODELS, ANIMAL; ELECTROPHYSIOLOGY; ISOMETRIC CONTRACTION; MICE; MUSCLE, SKELETAL; MYOTONIA; RATS; RATS, WISTAR;

EID: 31444445095     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.44.1247     Document Type: Article

References (21)

1. Harper PS. Myotonic disorders. In: Myology. 1st ed. Engel AG, Banker BQ, Eds. McGraw-Hill, New York, 1986: 1267-1311.
2. Carter JN, Steinbeck KS. Reduced adrenal androgens in patients with myotonic dystrophy. J Clin Endocrinol Metab 60: 611-614, 1985.
3. Sugino M, Ohsawa N, Ito T, et al. A pilot study of dehydroepiandroserone sulfate in myotonic dystrophy. Neurology 51: 558-589, 1998.
4. Lipicky RJ, Bryant SH, Salmon JH. Cable parameters, sodium, potassium, chloride, and water content, and potassium efflux in isolated external intercostal muscle of normal volunteers and patients with myotonia congenita. J Clin Invest 50: 2091-2103, 1971.
5. Brook JD, McCurrach ME, Harley HG, et al. Molecular basis of myotonic dystrophy: Expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member. Cell 68: 799-808, 1992
6. Mankodi A, Takahashi MP, Jiang H, et al. Expanded CUG repeats trigger aberrant splicing of CIC-1 chloride channel pre-mRNA and hyperexcitability of skeletal muscle in myotonic dystrophy. Mol Cell 10: 35-44, 2002.
7. Ebers GC, George AL, Barchi RL, et al. Paramyotonia congenita and hyperkalemic periodic paralysis are linked to the adult muscle sodium channel gene. Ann Neurol 30: 810-816, 1991.
8. Rüdel R, Ricker K, Lehmann-Horn F. Genotype-phenotype correlations in human skeletal muscle sodium channel diseases. Arch Neurol 50: 1241-1248, 1993.
9. Entrikin RK, Abresch RT, Scharman RB, et al. Contractile and EMG studies of murine myotonia (mto) and muscular dystrophy (dy/dy). Muscle Nerve 10: 293-298, 1987.
10. Mehrke G, Brinkmeier H, Jockusch H. The myotonic mouse mutant ADR: Electrophysiology of the muscle fiber. Muscle Nerve 11: 440-446, 1988.
11. Jockusch H, Bertram K, Schenk S. The genes for two neuromuscular diseases of the mouse, 'arrested development of righting response', adr, and 'myotonia', mto, are allelic. Genet Res Comb 52: 203-205, 1988.
12. Rüdel R. The myotonic mouse- a realistic model for the study of human recessive generalized myotonia. Trends Neurosci 13: 1-3, 1990.
13. Gronemeier M, Condie A, Prosser J, et al. Nonsense and missense mutations in the muscular chloride channel gene ClC-1 of myotonic Mice. J Biol Chem 269: 5963-5967, 1994.
14. Gurnett CA, Kahl SD, Anderson RD, et al. Absence of the skeletal muscle sarcolemma chloride channel ClC-1 in myotonic mice. J Biol Chem 270: 9035-9038, 1995.
15. Moxley III RT. Channelopathies. Curr Treat Options Neurol 2: 31-47, 2000.
16. Yang MT, Yang CC, Chu LW, et al. Schwartz-Jampel syndrome: report of one case. Acta Paediatr Taiwan 43: 220-223, 2002.
17. Kwiecinski H, Ryniewicz B, Ostrzycki A. Treatment of myotonia with antiarrhythmic drugs. Acta Neurol Scand 86: 371-375, 1992.
18. Jackson CE, Barohn RJ, Ptacek LJ. Paramyotonia congenita: abnormal short exercise test, and improvement after mexiletine therapy. Muscle Nerve 17: 763-768, 1994.
19. De Luca A, Pierno S, Natuzzi F, et al. Evaluation of the antimyotonic activity of mexiletine and some new analogs on sodium currents of single muscle fibers and on abnormal excitability of the myotonic ADR mouse. J Pharmacol Exp Ther 282: 93-100, 1997.
20. Kurihara T. Experimental myotonia. Folia Psychiatr Neurol Jpn 31: 653-660, 1977.
21. Imoto K, Kurihara T, Mori M, et al. Suppressive effect of dehydroepiandrosterone sulfate on myotonia by interacting with Na+ channel. The Proceedings of the Third International Myotonic Dystrophy Conference, Kyoto, Japan: 58, 2001 (Abstract).